Synthesis of curcumin derivatives targeting androgen receptor for castration‐resistant prostate cancer therapy
Jiangfei Liu,Yaohui Ni,Keyun Zhou,Guanzhao Wu,Liangyong Hu,Tianyu Zhu,Defeng Xu,Hang Hu
DOI: https://doi.org/10.1111/cbdd.14583
2024-07-13
Chemical Biology & Drug Design
Abstract:A series of curcumin derivatives (1a–1h, 2a–2g, 3a–3c) were synthesized for suppression of castration‐resistant prostate cancer cells. Compounds 1f and 2g show similar androgen receptor suppression effect as compared to ASC‐J9 on C4‐2 cells; compound 3c displays significantly enhanced AR suppression effect as compared to ASC‐J9. In this work, a series of curcumin derivatives (1a–1h, 2a–2g, and 3a–3c) were synthesized for the suppression of castration‐resistant prostate cancer cells. All synthesized compounds were characterized by 1H NMR, 13C NMR, HRMS, and melting point. The in vitro cytotoxicity study shows that compounds 1a, 1e, 1f, 1h, 2g, 3a, and 3c display similar or enhanced cytotoxicity against 22Rv1 and C4‐2 cells as compared to ASC‐J9, other synthesized compounds display reduced cytotoxicity against 22Rv1 and C4‐2 cells as compared to ASC‐J9. Molecular docking simulation was performed to study the binding affinity and probable binding modes of the synthesized compounds with androgen receptor. The results show that all synthesized compounds exhibit higher cdocker interaction energies as compared to ASC‐J9. Compounds 1h, 2g, and 3c not only show strong cytotoxicity against 22Rv1 and C4‐2 cells but also exhibit high binding affinity with androgen receptor. In androgen receptor suppression study, compounds 1f and 2g show similar androgen receptor suppression effect as compared to ASC‐J9 on C4‐2 cells, compound 3c displays significantly enhanced AR suppression effect as compared to ASC‐J9, 1f and 2g. Compounds 1a, 1e, 1f, 1h, 2g, 3a and 3c prepared in this work have significant potential for castration‐resistant prostate cancer therapy.
biochemistry & molecular biology,chemistry, medicinal